Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 4;9(3):003228.
doi: 10.12890/2022_003228. eCollection 2022.

Serotonin Surge: Intravenous Escitalopram as a Rare Cause of Drug-Induced Aplastic Anaemia

Murtaza Hussain  1 , Katherine Boyer  2 , Anoosha Ponnapalli  1 , Dominic Awuah  1 , Sina Khaneki  3 , Smit Deliwala  1 , Gassan Bachuwa  1
Affiliations

Serotonin Surge: Intravenous Escitalopram as a Rare Cause of Drug-Induced Aplastic Anaemia

Murtaza Hussain et al. Eur J Case Rep Intern Med. .

Abstract

Escitalopram is a commonly prescribed medication that has infrequently been implicated in drug-induced thrombocytopenia (DITP) but has never been associated with aplastic anaemia in the literature. We present an extremely rare case of hypoproliferative pancytopenia due to self-administered intravenous (IV) injection of escitalopram. The crux of this case is the unusual trilineage cytopenia. Our patient was managed with steroids and supportive care with subsequent clinical and blood count recovery. This case sheds light on this uncommon but important association.

Learning points: Escitalopram is an uncommon medication that could lead to drug-induced aplastic anaemia.The adverse effects of escitalopram on red cell, white cell and platelet counts may be exacerbated on intravenous administration of the medication.Timely diagnosis is vital for the effective treatment of severe aplastic anaemia, avoiding complications and preventing recurrence.

Keywords: Intravenous escitalopram; drug-induced aplastic anaemia; hypoproliferative pancytopenia.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interests: The Authors declare that there are no competing interests.

References

    1. Young NS. Acquired aplastic anemia. Ann Intern Med. 2002;136(7):534–546. - PubMed
    1. Bosch X, Vera M. Aplastic anaemia during treatment with fluoxetine. Lancet. 1998;351(9108):1031. - PubMed
    1. Vilinsky FD, Lubin A. Severe neutropenia associated with fluoxetine hydrochloride. Ann Intern Med. 1997;127(7):573–574. - PubMed
    1. Chu C-W, Chao P-C, Chang H-A, Liu Y-W, Chang T-C, Lin P-Y, et al. Escitalopram induced thrombocytopenia reversed after shifting to bupropion in a depressive patient. Aust N Z J Psychiatry. 2017;51(10):1055–1056. - PubMed
    1. Puneet D, Ravi K. Escitalopram induced persistent thrombocytopenia: a rare entity. Int J Med Health Sci. 2016;5(2):115–117.

LinkOut - more resources